VOYA Investment Management
HZNP

VOYA Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

VOYA Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-121,588
Closed -$14.1M – 2954
2023
Q3 		$14.1M Sell
121,588
-98,398
-45% -$10.6M 0.02% 599
2023
Q2 		$22.6M Buy
219,986
+135,060
+159% +$14.2M 0.02% 495
2023
Q1 		$9.27M Sell
84,926
-326,498
-79% -$36.1M 0.01% 756
2022
Q4 		$46.8M Sell
411,424
-277,743
-40% -$23.1M 0.05% 355
2022
Q3 		$42.7M Sell
689,167
-939,345
-58% -$65.6M 0.05% 350
2022
Q2 		$130M Sell
1,628,512
-1,041,954
-39% -$98.7M 0.33% 72
2022
Q1 		$281M Sell
2,670,466
-333,524
-11% -$32.5M 0.58% 28
2021
Q4 		$324M Sell
3,003,990
-318,972
-10% -$34.8M 0.62% 30
2021
Q3 		$364M Sell
3,322,962
-163,420
-5% -$17M 0.73% 20
2021
Q2 		$326M Buy
3,486,382
+299,267
+9% +$27.5M 0.63% 27
2021
Q1 		$293M Buy
3,187,115
+275,295
+9% +$23.2M 0.59% 28
2020
Q4 		$213M Sell
2,911,820
-955,006
-25% -$71M 0.43% 52
2020
Q3 		$300M Buy
3,866,826
+477,470
+14% +$32.9M 0.67% 21
2020
Q2 		$188M Buy
3,389,356
+3,238,687
+2,150% +$139M 0.44% 54
2020
Q1 		$4.46M Buy
150,669
+113,594
+306% +$3.84M 0.01% 722
2019
Q4 		$1.34M Sell
37,075
-17,817
-32% -$546K ﹤0.01% 1292
2019
Q3 		$1.5M Buy
+54,892
New +$1.42M ﹤0.01% 1133
2019
Q2 		– Sell
-71,312
Closed -$1.89M – 2664
2019
Q1 		$1.89M Buy
71,312
+2,405
+3% +$57K ﹤0.01% 1063
2018
Q4 		$1.35M Buy
68,907
+1,671
+2% +$32.8K ﹤0.01% 1163
2018
Q3 		$1.32M Hold
67,236
– – ﹤0.01% 1266
2018
Q2 		$1.11M Sell
67,236
-5,243
-7% -$79.9K ﹤0.01% 1325
2018
Q1 		$1.03M Sell
72,479
-979
-1% -$14.5K ﹤0.01% 1366
2017
Q4 		$1.07M Sell
73,458
-1,232
-2% -$17.3K ﹤0.01% 1386
2017
Q3 		$947K Sell
74,690
-685,121
-90% -$8.71M ﹤0.01% 1470
2017
Q2 		$9.02M Sell
759,811
-315,244
-29% -$3.92M 0.02% 638
2017
Q1 		$15.9M Buy
1,075,055
+128,291
+14% +$2.08M 0.04% 456
2016
Q4 		$15.3M Sell
946,764
-126,487
-12% -$2.29M 0.04% 440
2016
Q3 		$19.5K Buy
1,073,251
+1,003,825
+1,446% +$19.6M 0.04% 361
2016
Q2 		$1.14M Buy
+69,426
New +$1.12M ﹤0.01% 1207
2015
Q2 		– Sell
-38,447
Closed -$998K – 2679
2015
Q1 		$998K Sell
38,447
-3,478
-8% -$63.8K ﹤0.01% 1443
2014
Q4 		$540K Hold
41,925
– – ﹤0.01% 1877
2014
Q3 		$515K Hold
41,925
– – ﹤0.01% 1887
2014
Q2 		$663K Sell
41,925
-6,784
-14% -$96.8K ﹤0.01% 1782
2014
Q1 		$736K Hold
48,709
– – ﹤0.01% 1684
2013
Q4 		$371K Buy
+48,709
New +$263K ﹤0.01% 2181

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

VOYA Investment Management's HZNP Position: Q4 2023 in Review

VOYA Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 121,588 shares — an estimated $14.1M sold.

VOYA Investment Management first reported a position in HZNP in Q4 2013 and held it in 35 quarters. The position peaked at $364M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • VOYA Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • VOYA Investment Management sold 121,588 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $14.1M.
  • VOYA Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 35 quarters.
  • VOYA Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $364M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on VOYA Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.